Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CheelcareTSXV:CHER 6 Days Payable is 57.30 as of Apr. 2026, which is 68% below its 10-year median of 178.98. GuruFocus rates TSXV:CHER with a GF Score™ of 6/100. The stock has 6 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Cheelcare ranks better than 76.48% on this metric.
Cheelcare's average Accounts Payable for the
three
months ended in Apr. 2026 was C$0.51 Mil. Cheelcare's Cost of Goods Sold for the
three
months ended in Apr. 2026 was C$0.81 Mil.
Hence, Cheelcare's Days Payable for the
three
months ended in Apr. 2026 was 57.30.
The historical rank and industry rank for Cheelcare's Days Payable or its related term are showing as below:
TSXV:CHER'
s Days Payable Range Over the Past 10 Years
Min: 109.15 Med: 178.98 Max: 276.97
Current: 140.84
During the past 4 years, Cheelcare's highest Days Payable was 276.97. The lowest was 109.15. And the median was 178.98.
TSXV:CHER's Days Payable is ranked better than 76.48% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.41
vs TSXV:CHER: 140.84
Cheelcare's Days Payable
declined
from Apr. 2025 (262.93) to Apr. 2026 (57.30).
It may suggest that Cheelcareaccelerated paying its suppliers.
The historical data trend for Cheelcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:CHER vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Cheelcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cheelcare Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cheelcare's Days Payable distribution charts can be found below:
* The bar in red indicates where Cheelcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cheelcare's Days Payable for the fiscal year that ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cheelcare (TSXV:CHER) has a Days Payable of 57.30 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cheelcare and its competitors. This is 68% below median its historical median of 178.98. Over the past decade, Cheelcare's Days Payable has ranged from 109.15 to 276.97. According to the industry distribution chart, Cheelcare ranks #187 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 23.5%.
Is Cheelcare's Days Payable too high?
Cheelcare's current Days Payable of 57.30 is 68% below median its 10-year median of 178.98. Over the past 10 years, this metric has ranged from a low of 109.15 to a high of 276.97. The Medical Devices & Instruments industry median Days Payable is 68.41. Cheelcare's value of 57.30 is 16.2% below this industry median. Based on the distribution chart, Cheelcare ranks #187 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Cheelcare has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Cheelcare's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cheelcare ranks #187 out of 795 companies for Days Payable. This places Cheelcare in the top 24% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.41. Cheelcare's value of 57.30 is 16.2% below this benchmark. Historically, Cheelcare's own Days Payable has ranged from 109.15 to 276.97 over the past decade. While the company's 10-year median is 178.98 vs. the industry median of 68.41, Cheelcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.41, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cheelcare's current Days Payable of 57.30 is 16.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cheelcare and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cheelcare's current Days Payable is 57.30, which is 68% below median its own 10-year median of 178.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cheelcare stock overvalued right now?
Cheelcare (TSXV:CHER) has a current Days Payable of 57.30. The current Days Payable is 57.30, which is 68% below median its 10-year median of 178.98 and 16.2% below the Medical Devices & Instruments industry median of 68.41. Cheelcare's overall GF Score™ is 6/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cheelcare (TSXV:CHER), the current Days Payable is 57.30 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cheelcare Inc is a company that designs and manufactures inventive mobility devices using robotics. Its product portfolio consists of three key lines: Robotic Complex Rehab Power Wheelchair such devices feature patented self-leveling technology and the lowest seat-to-floor height in their class, enhancing stability and accessibility. Power Add-ons for Manual Wheelchairs designed to convert manual wheelchairs into powered mobility devices, offering users increased independence. Aftermarket Wheelchair Accessories includes a range of OEM equipment, backup cameras, phone chargers, and wheel suspension systems, that allow wheelchair users the ability to supplement their existing equipment to improve safety and convenience.
6GF Score
Get the complete analysis for TSXV:CHER
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:CHER has been successfully added to your 
